Institutional

Nikos K. Logothetis is a neuroscience professor at the Max Planck Institute and visited the Institut du Cerveau - ICM on December 14, 2015. In this interview, he explains how the NET-fMRI technique works, allowing scientists to record communications...

Ron R. Kopito, Professor of Biology at Stanford University, has been working for the last several years with his team on problems related to protein folding, which is notably affected in certain neurodegenerative diseases. In particular, protein...

The Behavioural Neuropsychiatry Unit (BNPU) is a clinical unit established in 2013 through the IHU-A-Institut du Cerveau - ICM in the framework of the “Investissements d’Avenir” in close cooperation with the APHP / Pitié Salpêtrière.

The Institut du Cerveau - ICM and the IHU-A-Institut du Cerveau - ICM announced in June, 2015, the launching of the "Big Brain Theory" program. This call for projects will attribute grants for new projects initiated by the researchers, clinicians...

In the framework of the new national Plan for the study of neurogenerative diseases (2014-2019), seven regional centres of excellence in the field of neurodegenerative diseases were selected from among the 12 projects submitted.

Dr. Claire Wyart leads a research team working on nerve networks of the spinal cord at the Brain and Spine Institute – Institut du Cerveau - ICM, Institut du Cerveau et de la moelle épinière – in Paris. In team with Dr Patrick Delmas from Marseille...

Neuroscience, Ethics and Society (NES) is an initiative of Institut du Cerveau - ICM, for the purpose of integrating ethics and neuroscience through education. Co-Directors of the project are Yves Agid, MD, PhD and Thomasine Kushner, PhD. To...

Nomination of Professor Alexis Brice as General Manager of the Brain & Spine Institute (Institut du Cerveau - ICM)

In the context of the second week of industry, Eric Besson, the minister of industry visited the site of Institut du Cerveau - ICM.

Institut du Cerveau et de la Moelle épiniѐre (Institut du Cerveau - ICM) and Pfizer have announced a three-year scientific collaboration to investigate the fundamental mechanisms of certain neurodegenerative diseases, including Alzheimer’s, Parkinson...